SCHEMBL4842585

SCHEMBL4842585

COC(=O)Cc1ccc(OCCNC(=O)C2Cc3c(OC)cccc3N2S(=O)(=O)c2ccc(-c3cccc(C(F)(F)F)c3)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 5/20 0.38
HCRTR1 O43613 1/20 0.38
HCRTR2 O43614 1/20 0.38
ADAMTS4 O75173 1/20 0.38
MMP13 P45452 1/20 0.38
ADAMTS5 Q9UNA0 1/20 0.38
MMP1 P03956 1/20 0.37
ADAM17 P78536 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
RECQL P46063 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
PLAU P00749 1/20 0.36
PLAT P00750 1/20 0.36
NPC1 O15118 1/20 0.36
MEN1 O00255 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4841399 0.95 RORC (0.41) RORCHCRTR1HCRTR2ADAMTS4MMP13
SCHEMBL4840659 0.90 BACE1 (0.43) RORCHCRTR1HCRTR2ALDH1A1CYP3A4
SCHEMBL4841819 0.90 RORC (0.41) RORCHCRTR1HCRTR2ADAMTS4MMP13
SCHEMBL4841421 0.85 RORC (0.40) RORCADAMTS4MMP13ADAMTS5MMP1
SCHEMBL4839181 0.85 BACE1 (0.43) RORCNPC1TRPA1BACE1
SCHEMBL4840723 0.85 MCHR1 (0.40) RORCALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL4841876 0.85 RORC (0.39) RORCADAMTS4MMP13ADAMTS5MMP1
SCHEMBL4840814 0.83 MAPT (0.38) RORCALDH1A1NPSR1LMNAMAPT
SCHEMBL4837122 0.83 RORC (0.43) RORCADAMTS4MMP13ADAMTS5MMP1
SCHEMBL4837344 0.83 RORC (0.43) RORCADAMTS4MMP13ADAMTS5MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 US disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119465-A1 Novel Indoline Compounds GPR119, INSR, IRS1 RORC 1777/4885HCRTR1 41/4885HCRTR2 142/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.